Boston Scientific is recommended as a buy with a $109 target price, implying 14% upside, driven by robust demand and niche leadership. BSX outpaces market growth through focused M&A, strong execution ...
MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 th, 2026, in ...
Another month, and another annoying carriage dispute threatens to block sports fans from watching a game (or games) on a provider they’re paying for. At jeopardy this time is Sunday’s Patriots-Jets ...
Boston Scientific’s BSX Cardiovascular segment operates in a $50 billion market, projected to grow nearly 9% over the 2026-2028 long-range plan (LRP). Management expects the business to outpace ...
Foundational Concepts in Programming Industrial Robots. Before you can get a robot to do anything useful, you need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results